1.Global tuberculosis report 2018 Geneva: World Health Organization; [updated 2018; cited 2019 April]. Available from: http://www.who.int/tb/publications/global_report/en/.
2.Phuong NT, Nhung NV, Hoa NB, Thuy HT, Takarinda KC, Tayler-Smith K, et al. Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam. Public health action. 2016;6(1):25–31.
3.Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, et al. Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine. BMC infectious diseases. 2017;17(1):129.
4.Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, et al. Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. Tuberculosis. 2012;92(5):397–403.
5.van Altena R, de Vries G, Haar CH, de Lange WC, Magis-Escurra C, van den Hof S, et al. Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000–2009. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2015;19(4):406–12.
6.Brust JC, Gandhi NR, Carrara H, Osburn G, Padayatchi N. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000–2003. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2010;14(4):413–9.
7.Nhung NV, Hoa NB, Sy DN, Hennig CM, Dean AS. The fourth national anti-tuberculosis drug resistance survey in Viet Nam. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2015;19(6):670–5.
8.Hoa NB, Khanh PH, Chinh NV, Hennig CM. Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam. Tropical medicine & international health: TM & IH. 2014;19(9):1076–81.
9.Technical manual for drug susceptibility testing of medicines used in the treatment of tuberculosis. Geneva: World Health Organization; 2018 [updated 2018; cited 2019 March]. Available from: https://www.who.int/tb/publications/2018/WHO_technical_drug_susceptibility_testing/en/.
10.Nunn AJ, Rusen ID, Van Deun A, Torrea G, Phillips PP, Chiang CY, et al. Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial. Trials. 2014;15:353.
11.Team RC. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing;. 2015.
12.Organization WH. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis 2014 [cited 2019 March]. Available from: https://www.who.int/tb/publications/pmdt_companionhandbook/en/.
13.Stef van Buuren KG-O. mice: Multivariate Imputation by Chained Equations in R. Journal of Statistical Software,. 2011;2018(August):1–67.
14.Mai TQ, Martinez E, Menon R, Van Anh NT, Hien NT, Marais BJ, et al. Mycobacterium tuberculosis Drug Resistance and Transmission among Human Immunodeficiency Virus-Infected Patients in Ho Chi Minh City, Vietnam. The American journal of tropical medicine and hygiene. 2018;99(6):1397–406.
15.Nhu NT, Lan NT, Phuong NT, Chau N, Farrar J, Caws M. Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2012;16(4):527–31.
16.Hang NT, Maeda S, Lien LT, Thuong PH, Hung NV, Thuy TB, et al. Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors. PloS one. 2013;8(8):e71867.
17.Kwak N, Kim HR, Yoo CG, Kim YW, Han SK, Yim JJ. Multidrug-resistant tuberculosis over 20 years at a referral hospital in South Korea: trends and outcomes. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2019;23(2):174–80.
18.Gunther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, et al. Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries. American journal of respiratory and critical care medicine. 2018;198(3):379–86.
19.World Health Organization treatment guidelines for drug-resistant tuberculosis 2016 update: World Health Organization; 2016.
20.Nguyen HB, Nguyen NV, Tran HT, Nguyen HV, Bui QT. Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011. Western Pacific surveillance and response journal: WPSAR. 2016;7(2):35–40.
21.Vu DH, van Rein N, Cobelens FG, Nguyen TT, Le VH, Brouwers JR. Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2012;16(12):1625–9.
22.Hoa NB, Phuc PD, Hien NT, Hoa VQ, Thuong PH, Anh PT, et al. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in Hanoi, Vietnam. BMC infectious diseases. 2018;18(1):603.
23.Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes research and clinical practice. 2014;103(2):137–49.
24.Magee MJ, Kempker RR, Kipiani M, Gandhi NR, Darchia L, Tukvadze N, et al. Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2015;19(6):685–92.
25.Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC medicine. 2011;9:81.
26.Salindri AD, Kipiani M, Kempker RR, Gandhi NR, Darchia L, Tukvadze N, et al. Diabetes Reduces the Rate of Sputum Culture Conversion in Patients With Newly Diagnosed Multidrug-Resistant Tuberculosis. Open forum infectious diseases. 2016;3(3):ofw126.
27.Alarcon V, Alarcon-Arrascue E, Mendoza-Ticona A, Obregon G, Cornejo J, Vargas D, et al. Programmatic management of patients with pre-extensively drug-resistant tuberculosis in Peru, 2011–2014. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2018;22(10):1220–6.
28.Kang YA, Kim SY, Jo KW, Kim HJ, Park SK, Kim TH, et al. Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis. Respiration; international review of thoracic diseases. 2013;86(6):472–8.
29.Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PloS one. 2009;4(9):e6914.
30.Singhal A, Jie L, Kumar P, Hong GS, Leow MK, Paleja B, et al. Metformin as adjunct antituberculosis therapy. Science translational medicine. 2014;6(263):263ra159.
31.Degner NR, Wang JY, Golub JE, Karakousis PC. Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2018;66(2):198–205.
32.Miller AC, Gelmanova IY, Keshavjee S, Atwood S, Yanova G, Mishustin S, et al. Alcohol use and the management of multidrug-resistant tuberculosis in Tomsk, Russian Federation. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2012;16(7):891–6.
33.Fan YM, Ding SP, Bao ZJ, Wu LM, Zhen LB, Xia Q, et al. Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease. 2018;22(3):300–5.